Trial intelligence / Profile preview

Femoral nerve block versus placebo for pain control in older adults with proximal femoral fracture

NL-OMON45916Withdrawn

Sponsor
Reinier de Graaf Hospital
Start
Feb 2016
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial in hip fracture comparing Levobupivacaine femoral nerve block with Placebo sham injection (2 arms). Primary endpoints: Raw pain intensity difference up to 4 hours after femoral nerve block, Percentage of patients with complications and 1 more. Planned start Feb 2016; status: withdrawn.

02

Drugs

levobupivacaine
03

Conditions

hip fracture

Beyond the preview

Go deeper on NL-OMON45916.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON45916.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call